Brexit: Biotech looks to Switzerland for a new strategy
Nine months after the historic referendum in which the UK population voted to leave the European Union, the UK government has at last served notice to quit.
Theresa May yesterday signed the letter that will formally begin the UK’s departure from the European Union, starting a process which will eventually make clear how the country will trade with the EU and the rest of the world.
Since the Brexit vote last summer, the UK life sciences sector have been seeking answers as how it can trade and collaborate with Europe, and continue to flourish as a centre for science and innovation.